Delivery Order SPE2DB20D3104-SPE2DB23FV8X2
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,654.16 fixed-price delivery order is for the supply of 4567222493 - SOL IV 0.9% NACL 100ML 1 DS PWDR DRG VL, with a completion date of February 11, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which...
- This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,811.42 firm fixed-price delivery order is for the supply of a medical product, specifically 4565800881 ! SOL IV 0.9% NACL 100ML 1 DS PWDR DRG VL. The contract has an ultimate completion date of September 16, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with government agencies, including a...
- This federal contract award is for the delivery of 0.9% sodium chloride solution (50 ml) to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $11,401.08 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is associated with a larger indefinite delivery contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a for-profit organization. The $1,241.30 firm fixed price delivery order is for the supply of 4565076088 - SOL IV 0.9% NACL 100ML 1 DS PWDR DRG VL, with a period of performance through July 8, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,698.72 firm fixed-price delivery order is for the supply of 4557172583 - SOL IV 0.9% NACL 250ML PLS CNTNR VFLX LF, a pharmaceutical product. The award has an ultimate completion date of May 11, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies,...
- The federal contract award is for the delivery of 0.9% sodium chloride solution, 100ml, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, as a delivery order with a ceiling value of $1,062.67. The contract has a firm fixed price and an ultimate completion date of September 28, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,654.16, is a delivery order for 4567199525 - SOL IV 0.9% NACL 100ML 1 DS PWDR DRG VL. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award, valued at $1,707.50, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
- This federal contract award is a Delivery Order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,328.29 Firm Fixed Price contract is for the delivery of 4560762542 - SOL IV 0.9% NACL 500ML PLS CNTNR VFLX LF medical products. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor for this award, which is...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company owned by Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price, valued at $3,027.28, for the supply of a medical product, specifically 4560774400 ! SOL IV 0.9% NACL 50ML 1 DS PWDR DRG VL. The contract has a period of performance through May 2, 2023. This award is not associated with a set-aside designation, indicating open...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB23FV8X2Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,470.33 firm fixed-price delivery order is for the supply of a specific medical product, 4562101570 - SOL IV 0.9% NACL 100ML 1 DS PWDR DRG VL. The award does not have a set-aside designation, indicating open competition. The prime contractor, Amerisourcebergen Drug Corp, is a subsidiary of the parent company Cencora, Inc. This contract is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support the healthcare needs of the Department of Defense and other federal agencies. The contract has an ultimate completion date of September 11, 2023.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/8/23 |